Comorbid Chronic Diseases and Ventilatory Support in COVID-19 Hospitalisations
Description
No abstract
PubMed COVID-19 Clinical Care
41 - 50 of 44979 results found
Home participation and personal and environmental factors in children and adolescents with Down syndrome
Description
AIM: To describe current home participation (frequency, involvement) and caregiver's desire for change in home participation of children and adolescents with Down syndrome, as well as home environmental factors, and to explore the associations of
Description and Analysis of Research on Death and Dying during the COVID-19 Pandemic, Published in Nursing Journals Indexed in SCOPUS
Description
CONCLUSION: The results obtained offer a range of data and images that characterize the scientific production published on this topic, coming to the conclusion that, due to the multifaceted and multidisciplinary approach to the experience of death
Lower respiratory tract infection admissions and deaths among children under 5 years in public sector facilities in the Western Cape Province, South Africa, before and during the COVID-19 pandemic (2019 - 2021)
Description
CONCLUSIONS: The COVID-19 surges and their associated measures were linked to declining LRTI admissions and in-facility deaths, likely driven by a combination of reduced infectious disease transmission and reduced use of healthcare services, with
Co-Occurrence Analysis of COVID-19 Publications with an Emphasis on the Global Health Governance (GHG)
Description
CONCLUSION: The global approach of studies related to COVID-19 is more inclined to the epidemiological and public health fields. Assuming the GHG, detailed and comprehensive planning should be performed to strengthen these studies and pave the way
Molecular Property Diagnostic Suite for COVID-19 (MPDS(COVID-19)): an open-source disease-specific drug discovery portal
Description
Molecular Property Diagnostic Suite (MPDS) was conceived and developed as an open-source disease-specific web portal based on Galaxy. MPDS^(COVID-19) was developed for COVID-19 as a one-stop solution for drug discovery research. Galaxy platforms
Revolutionizing Antiviral Therapeutics: Unveiling Innovative Approaches for Enhanced Drug Efficacy
Description
Since the beginning of the coronavirus pandemic in late 2019, viral infections have become one of the top three causes of mortality worldwide. Immunization and the use of immunomodulatory drugs are effective ways to prevent and treat viral infections
Association of PADI2 and PADI4 polymorphisms in COVID-19 host severity and non-survival
Description
CONCLUSIONS: Our results suggest that the haplotypic combination of GTACC and some individual genotypes of PADI2 and PADI4 contribute to the subjects' susceptibility for severity and death by COVID-19.
Clinical Characteristics and Severity of Respiratory Syncytial Virus infection in Korean Children during the Post-COVID-19 Pandemic Period
Description
We aimed to evaluate the clinical features of respiratory syncytial virus (RSV) infection and risk factors for severe RSV disease among Korean children in 2022/2023. A total of 235 children were identified, and 84.3% were hospitalized. Patients under
Clinical characteristics of hospitalized children with respiratory syncytial virus infection and risk prediction of severe illness during the post-COVID-19 era in Kunming
Description
Objective: To compare the epidemiological and clinical characteristics of hospitalized children with respiratory syncytial virus (RSV) infection in Kunming among the pre-and post-COVID-19 era, and to establish a prediction model for severe RSV